Spitfire Capital Lowers stake in U.S. Physical Therapy (USPH)

U.S. Physical Therapy (USPH) : Spitfire Capital reduced its stake in U.S. Physical Therapy by 43.58% during the most recent quarter end. The investment management company now holds a total of 125,678 shares of U.S. Physical Therapy which is valued at $7,691,494 after selling 97,063 shares in U.S. Physical Therapy , the firm said in a disclosure report filed with the SEC on Aug 12, 2016.U.S. Physical Therapy makes up approximately 3.22% of Spitfire Capital’s portfolio.

Other Hedge Funds, Including , Marshall Wace Llp reduced its stake in USPH by selling 10,286 shares or 68.28% in the most recent quarter. The Hedge Fund company now holds 4,778 shares of USPH which is valued at $292,414.Bard Associates Inc reduced its stake in USPH by selling 270 shares or 0.32% in the most recent quarter. The Hedge Fund company now holds 83,113 shares of USPH which is valued at $5,086,516. U.S. Physical Therapy makes up approx 2.54% of Bard Associates Inc’s portfolio. Alambic Investment Management sold out all of its stake in USPH during the most recent quarter. The investment firm sold 6,050 shares of USPH which is valued $370,684.Boston Partners boosted its stake in USPH in the latest quarter, The investment management firm added 3,584 additional shares and now holds a total of 158,773 shares of U.S. Physical Therapy which is valued at $9,718,495. U.S. Physical Therapy makes up approx 0.01% of Boston Partners’s portfolio.California Public Employees Retirement System boosted its stake in USPH in the latest quarter, The investment management firm added 700 additional shares and now holds a total of 59,500 shares of U.S. Physical Therapy which is valued at $3,477,775. U.S. Physical Therapy makes up approx 0.01% of California Public Employees Retirement System’s portfolio.

U.S. Physical Therapy opened for trading at $62.2 and hit $62.565 on the upside on Monday, eventually ending the session at $62.56, with a gain of 0.79% or 0.49 points. The heightened volatility saw the trading volume jump to 37,946 shares. Company has a market cap of $783 M.

On the company’s financial health, U.S. Physical Therapy reported $0.57 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Aug 4, 2016. Analyst had a consensus of $0.55. The company had revenue of $90.40 million for the quarter, compared to analysts expectations of $90.37 million. The company’s revenue was up 8.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.51 EPS.

Many Wall Street Analysts have commented on U.S. Physical Therapy. U.S. Physical Therapy was Downgraded by Barrington Research to ” Mkt Perform” on Aug 5, 2016.

U.S. Physical Therapy Inc. through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders sports-related injuries preventative care rehabilitation of injured workers and neurological-related injuries. The Company primarily operates through subsidiary clinic partnerships in which it owns a 1% general partnership interest and a 64% limited partnership interest and the managing therapists of the clinics owns the remaining limited partnership interest in the clinics. The Company provides services at its clinics on an outpatient basis. Patients are treated for approximately one hour per day two to three times a week for two to six weeks. The Company operates approximately 489 clinics in 42 states of the United States.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *